The AI for Good Lab is part of Microsoft’s philanthropic initiatives and partners with changemakers across the globe, providing computing power, AI experts and data scientists to help organizations’ subject matter experts in their work. This round of grantees includes the University of Washington’s Institute for Protein Design, Washington State University, Virufy, Providence, and the Institute for Health Metrics and Evaluation, among others.

These investments underscore Washington’s leadership in AI and life sciences and its commitment to fostering homegrown innovation.

The post Microsoft’s AI for Good Lab Invests in 20 State Change-Makers appeared first on Life Science Washington.

As part of the partnership, AGC Biologics will develop the cell line and create a master cell bank (MCB) for Novelty Nobility’s bispecific antibody candidate at its Copenhagen facility. Novelty Nobility will leverage AGC Biologics’ expertise, proprietary CHEF1 expression technology, and additional process development.

The post AGC Biologics & Novelty Nobility Partner for Cell Line Development appeared first on Life Science Washington.

The post Alpenglow Biosciences, an LSW Institute WIN Graduate, and ZEISS Launch Advanced Inverted Light-Sheet Microscopy Platform for Research and Clinical Use appeared first on Life Science Washington.

In the first 100 days of President Donald Trump’s administration, hundreds of active research grants have been canceled or threatened nationwide. Now, the administration might propose deep cuts to the Food and Drug Administration, National Institutes of Health and other federal health agencies. 

Buckner was speaking last month at Life Science Innovation Northwest, Seattle’s marquee gathering of the biotech industry. Most years, the two-day conference sees scientists, investors and others involved in the region’s $41 billion biotech industry dish about the latest discoveries and collaborations for treating diseases and improving health, while making deals, scoring jobs or just getting some good advice.

The post As Trump Attacks Science, WA’s $41B Biotech Sector Caught in Crossfire appeared first on Life Science Washington.

Gestalt’s technology aims to improve cancer detection, allowing for real-time collaboration between health providers and pathologists and faster diagnosis.

The new funding will support efforts to reach more customers, improve the tool’s AI capabilities, and aid in the pursuit of Food and Drug Administration clearance. The digital analysis technology is increasingly important, the startup notes, given the rising cancer rates and declining number of pathologists.

“We’ve already streamlined how pathologists navigate fragmented systems by creating PathFlow, a unified platform for viewing pathology cases digitally and collaborating with leading experts in real-time without the need to ship specimens,” Gestalt CEO Dan Roark said in a statement. “Now, we’ll accelerate innovation and scale our reach to meet the growing demands of modern pathology.”

The post Spokane Startup Gestalt Diagnostics Raises $7.5M to Advance AI-Enabled Cancer Detection appeared first on Life Science Washington.

The post Curi Bio and Cook MyoSite Announce Strategic Partnership appeared first on Life Science Washington.

The post HSSA Expands its Scope, Invests in Startups appeared first on Life Science Washington.

The post Seattle Children’s Moves into New Denny Triangle Research Tower appeared first on Life Science Washington.

“These studies represent critical contributions to our better understanding of women’s health,” Andrew Nixon, a spokesman for the Department of Health and Human Services, told NPR.

The National Institutes of Health launched the Women’s Health Initiative (WHI) in 1991 and more than 161,000 women participated in early studies. Some 42,000 women aged 78 to 108 are currently enrolled in WHI research and have been involved with the project for decades.

WHI is led by Seattle’s Fred Hutch Cancer Center and includes four regional centers: Stanford University, University of Buffalo, Ohio State University and Wake Forest University in North Carolina. The centers learned a week ago their contracts would end in September, and Fred Hutch could continue operations until January 2026, “after which time its funding remains uncertain,” the WHI said.

The post Feds May Reinstate Cancelled Funding for Signature Women’s Health Study Led by Fred Hutch appeared first on Life Science Washington.

The post Nobel Winner David Baker on Moving from the ‘Lunatic Fringe’ to the Protein Design Revolution at Life Science Innovation Northwest 2025 appeared first on Life Science Washington.